| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/31/2000 | EP1003533A1 Use of herpes vectors for tumor therapy |
| 05/31/2000 | EP1003528A1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 05/31/2000 | EP1003514A1 Cyclic amine modulators of chemokine receptor activity |
| 05/31/2000 | EP1003509A1 Il-8 receptor antagonists |
| 05/31/2000 | EP1003507A1 Combination therapy comprising amlodipine and a statin compound |
| 05/31/2000 | EP1003504A2 Indole derivatives and their use as mcp-1 antagonists |
| 05/31/2000 | EP1003503A1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 05/31/2000 | EP1003497A1 Il-8 receptor antagonists |
| 05/31/2000 | EP1003492A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 05/31/2000 | EP1003479A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 05/31/2000 | EP0865428B1 Vitamin d analogues |
| 05/31/2000 | EP0689440B1 Use of triazine compounds as anxiolytics |
| 05/31/2000 | EP0633775B1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
| 05/31/2000 | DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs |
| 05/31/2000 | DE19854749A1 Verwendung von Kapseln, die eine oder mehrere antigene Substanzen enthalten, zur Prävention und/oder Behandlung von Autoimmunerkrankungen The use of capsules which contain one or more antigenic substances, for the prevention and / or treatment of autoimmune diseases |
| 05/31/2000 | CN1255060A Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 05/31/2000 | CN1255041A Methods and compositions for treatment of aids-associated kaposi's sarcoma |
| 05/31/2000 | CN1254590A Medicinal liquor |
| 05/31/2000 | CN1254589A Medicine for treating Baisai's disease and its preparing process |
| 05/31/2000 | CN1052892C Medicine for treating AIDS and preparing method |
| 05/30/2000 | US6069230 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 05/30/2000 | US6069163 Azapeptide acids as cell adhesion inhibitors |
| 05/30/2000 | US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/30/2000 | US6069156 Indole derivatives as cGMP-PDE inhibitors |
| 05/30/2000 | US6069139 Method and composition for prophulaxis and treatment of retinal diseases |
| 05/30/2000 | US6069135 Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents |
| 05/30/2000 | US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections |
| 05/30/2000 | US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells |
| 05/30/2000 | US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease |
| 05/30/2000 | US6068840 Recombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4 |
| 05/30/2000 | CA2063416C Methods of treating or preventing autoimmune uveoretinitis mammals |
| 05/25/2000 | WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
| 05/25/2000 | WO2000029580A1 Calcium binding protein |
| 05/25/2000 | WO2000029574A2 Inflammation-associated genes |
| 05/25/2000 | WO2000029445A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029425A1 Physiologically active peptides |
| 05/25/2000 | WO2000029422A1 31 human secreted proteins |
| 05/25/2000 | WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | WO2000029389A1 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity |
| 05/25/2000 | WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 05/25/2000 | WO2000029381A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 05/25/2000 | WO2000029016A1 Intradermal avian immunization with inactivated vaccines |
| 05/25/2000 | WO2000029014A1 Method of treating heparin-induced thrombocytopenia |
| 05/25/2000 | WO2000029001A1 Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation |
| 05/25/2000 | WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 05/25/2000 | WO2000028947A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 05/25/2000 | WO2000028943A2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 05/25/2000 | WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 05/25/2000 | WO2000015788A3 Dna sequence encoding oncofetal ferritin protein |
| 05/25/2000 | WO2000012111A3 Selective treatment of endothelial somatostatin receptors |
| 05/25/2000 | WO2000010595A3 Medicaments for manipulating t-cell immune response |
| 05/25/2000 | WO2000000825A9 Detection and modulation of cellular immunity to immune privileged antigens |
| 05/25/2000 | DE19955793A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists |
| 05/25/2000 | DE19853487A1 Use of dialkyl fumarate for treating transplant rejection and autoimmune disease |
| 05/25/2000 | DE19853066A1 Use of hyaluronic acid fragments in vaccine production, especially for cancer treatment |
| 05/25/2000 | DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases |
| 05/25/2000 | CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | CA2351067A1 Method of treating heparin-induced thrombocytopenia |
| 05/25/2000 | CA2350785A1 31 human secreted proteins |
| 05/25/2000 | CA2350443A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 05/25/2000 | CA2350415A1 Inflammation-associated genes |
| 05/25/2000 | CA2350389A1 Calcium binding protein |
| 05/25/2000 | CA2349919A1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 05/25/2000 | CA2349431A1 Intradermal avian immunization with inactivated vaccines |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | CA2347914A1 Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation |
| 05/24/2000 | EP1002792A1 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| 05/24/2000 | EP1002545A1 Suppressive agent against expression of cell adhesion molecules |
| 05/24/2000 | EP1002542A1 Method for treating the endotoxic shock in mammals |
| 05/24/2000 | EP1002539A1 Immunomodulator comprising bacterial cells or cell wall decomposition products thereof |
| 05/24/2000 | EP1002108A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/24/2000 | EP1002099A1 Synaptojanin isoform |
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1002076A1 Proteins mediating switch recombination |
| 05/24/2000 | EP1001990A1 Protein that binds trail |
| 05/24/2000 | EP1001974A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001955A1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 05/24/2000 | EP1001807A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases |
| 05/24/2000 | EP1001806A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 05/24/2000 | EP1001805A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| 05/24/2000 | EP1001798A1 Method for preventing or treating a human immunodeficiency virus infection |
| 05/24/2000 | EP1001782A1 5,6-HETEROARYL-DIPYRIDO 2,3-$i(b):3',2'-$i(f)]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
| 05/24/2000 | EP1001766A1 Compounds and methods |
| 05/24/2000 | EP1001764A1 Heterocyclic amide compounds as cell adhesion inhibitors |
| 05/24/2000 | EP1001753A1 Low dosed 15-desoxyspergualine preparations |
| 05/24/2000 | EP1001685A1 Nutritional composition containing methionine |
| 05/24/2000 | EP0725629B1 Liposomal defensins |
| 05/24/2000 | EP0724452B1 Pharmaceutical composition containing cyclosporine a, a vitamine e derivative and an emulsifier |
| 05/24/2000 | EP0652764B1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 05/24/2000 | EP0626969B1 CoA-IT AND PAF INHIBITORS |
| 05/24/2000 | CN1254341A Pharmaceutically accpetable salts of 3-hydroxy-estr-5-(10)-en-17-one 3-sulphate active as estrogens |
| 05/24/2000 | CN1254335A Nicotinamide derivatives |
| 05/24/2000 | CN1254333A Immunotherapeutic imides/amides |
| 05/24/2000 | CN1253833A Cell adhesion molecule expression inhibitor |
| 05/24/2000 | CN1052733C Immuno-stimulatory monoclonal antibodies |
| 05/24/2000 | CN1052639C Traditional Chinese medicine capsule for curing rheumatoid arthritis |